Albany, NY: Allen W. Zieker, M.D., President and Director of Cataract Surgery at Ophthalmic Consultants of the Capital Region, was chosen to be the first cataract surgeon in the United States to implant the new Bausch + Lomb enVista® toric MX60T intraocular lens. Bausch + Lomb, a leading global eye health company, announced they received approval July 30, 2018, from the U.S. Food and Drug Administration (FDA) for the enVista toric MX60T, the company’s first hydrophobic acrylic intraocular lens (IOL) for astigmatism correction. Dr. Allen W. Zieker performed cataract surgery and implanted the enVista toric MX60T IOL in four patients on July 31, 2018.

The enVista toric MX60T IOL provides superb rotation stability for cataract patients needing astigmatism correction. “enVista’s new technology comes with proven clinical results,” explained Dr. Allen W. Zieker. “I’m honored to be the first cataract surgeon in the United States to implant the enVista toric MX60T and excited to offer it to my astigmatic cataract patients.”